Literature DB >> 15780480

Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.

D Peleg-Raibstein1, M A Pezze, B Ferger, W-N Zhang, C A Murphy, J Feldon, T Bast.   

Abstract

Many behavioral functions-including sensorimotor, attentional, memory, and emotional processes-have been associated with hippocampal processes and with dopamine transmission in the medial prefrontal cortex (mPFC). This suggests a functional interaction between hippocampus and prefrontal dopamine. The anatomical substrate for such an interaction is the intimate interconnection between the ventral hippocampus and the dopamine innervation of the mPFC. The present study yielded direct neurochemical evidence for an interaction between ventral hippocampus and prefrontal dopamine transmission in rats by demonstrating that subconvulsive stimulation of the ventral hippocampus with N-methyl-d-aspartate (NMDA; 0.5 mug/side) activates dopamine transmission in the mPFC. Postmortem measurements revealed that bilateral NMDA stimulation of the ventral hippocampus, resulting in locomotor hyperactivity, increased the homovanillic acid/dopamine ratio, an index of dopamine transmission, in the mPFC; indices of dopamine transmission in any of five additionally examined forebrain regions (amygdala, nucleus accumbens shell/core, lateral prefrontal cortex, caudate putamen) were unaltered. In vivo microdialysis measurements in freely moving rats corroborated the suggested activation of prefrontal dopamine transmission by demonstrating that unilateral NMDA stimulation of the ventral hippocampus increased extracellular dopamine in the ipsilateral mPFC. The suggested influence of the ventral hippocampus on prefrontal dopamine may be an important mechanism for hippocampo-prefrontal interactions in normal behavioral processes. Moreover, it indicates that aberrant hippocampal activity, as found in neuropsychiatric diseases, such as schizophrenia and mood disorders, may contribute to disruption of certain cognitive and emotional functions which are extremely sensitive to imbalanced prefrontal dopamine transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780480     DOI: 10.1016/j.neuroscience.2004.12.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Distinct contributions of hippocampal NMDA and AMPA receptors to encoding and retrieval of one-trial place memory.

Authors:  Tobias Bast; Bruno M da Silva; Richard G M Morris
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

2.  Imaging of brain dopamine pathways: implications for understanding obesity.

Authors:  Gene-Jack Wang; Nora D Volkow; Panayotis K Thanos; Joanna S Fowler
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

3.  The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults.

Authors:  Stefan Ehrlich; Eric M Morrow; Joshua L Roffman; Stuart R Wallace; Melissa Naylor; H Jeremy Bockholt; Antonia Lundquist; Anastasia Yendiki; Beng-Choon Ho; Tonya White; Dara S Manoach; Vincent P Clark; Vince D Calhoun; Randy L Gollub; Daphne J Holt
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

Review 4.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry.

Authors:  Gene-Jack Wang; Julia Yang; Nora D Volkow; Frank Telang; Yeming Ma; Wei Zhu; Christopher T Wong; Dardo Tomasi; Panayotis K Thanos; Joanna S Fowler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-05       Impact factor: 11.205

6.  Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia.

Authors:  Byron K Y Bitanihirwe; Daria Peleg-Raibstein; Forouhar Mouttet; Joram Feldon; Urs Meyer
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 7.  Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.

Authors:  Tobias Bast; Marie Pezze; Stephanie McGarrity
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

8.  Baseline prepulse inhibition expression predicts the propensity of developing sensitization to the motor stimulant effects of amphetamine in C57BL/6 mice.

Authors:  Daria Peleg-Raibstein; Jonas Hauser; Luis H Llano Lopez; Joram Feldon; Pascual A Gargiulo; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2012-08-17       Impact factor: 4.530

9.  Catecholaminergic depletion within the prelimbic medial prefrontal cortex enhances latent inhibition.

Authors:  A J D Nelson; K E Thur; C A Marsden; H J Cassaday
Journal:  Neuroscience       Date:  2010-07-07       Impact factor: 3.590

10.  COMT val108/158 met genotype affects neural but not cognitive processing in healthy individuals.

Authors:  Nancy A Dennis; Anna C Need; Kevin S LaBar; Sheena Waters-Metenier; Elizabeth T Cirulli; James Kragel; David B Goldstein; Roberto Cabeza
Journal:  Cereb Cortex       Date:  2009-07-29       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.